Navigation Links
U.S. Food and Drug Administration Advisory Committee Recommends Approval of Tolvaptan, an Investigational Treatment for Hyponatremia
Date:6/25/2008

PRINCETON, N.J., Jun. 25 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) Advisory Committee on Cardiovascular and Renal Drugs voted to recommend the approval of tolvaptan, Otsuka Pharmaceutical Development & Commercialization, Inc.'s (OPDC) investigational treatment for patients with hyponatremia.

"Otsuka is pleased that the FDA Advisory Committee supports the potential approval of tolvaptan, an investigational selective V2-vasopressin receptor antagonist," said Taro Iwamoto, Ph.D., Chief Executive Officer, President and Chief Operating Officer of OPDC. "We believe tolvaptan, if approved by the FDA, has the potential to be an important treatment option for people with hyponatremia."

Hyponatremia, characterized by low concentrations of sodium in the blood, is a known predictor of mortality in patients with serious underlying illnesses.(i) Sodium is an important electrolyte that plays a role in blood pressure maintenance, muscle movement, and fluid regulation in and around cells.(ii) Approximately 3.2 million to 6.1 million people in the U.S. suffer from hyponatremia annually.(iii)

Tolvaptan is an investigational selective antagonist of the vasopressin V2 receptor, which is located predominantly in the kidney and plays a role in the regulation of fluid retention in the body. Vasopressin V2 antagonists work by selectively blocking the V2 receptor. This mechanism of action hinders water reabsorption and results in increased free water excretion (aquaresis), which is characterized by increased urine volume with no increase in urinary electrolyte excretion.

OPDC was established in 2007 by Otsuka America, Inc. (OAI). OPDC is wholly owned by OAI, which is the holding company for Otsuka Pharmaceutical Co., Ltd. (OPC) interests in the U.S. OAI is wholly owned by OPC.

About Otsuka Pharmaceutical Development & Commercialization, Inc.

Otsuka Pharmaceutical Development & Commercialization (OPDC) is involved in conductin
'/>"/>

SOURCE Otsuka Pharmaceutical Development & Commercialization,Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
2. Bioscrypts V-Station MIFARE Placed on Transportation Security Administrations Qualified Products List
3. Australian Therapeutics Goods Administration Approval for ActiPatch Achieved
4. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
5. Korean Food and Drug Administration Approval for ActiPatch Achieved
6. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
7. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
8. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
9. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
10. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
11. PPD Confirms Takedas NDA Filing of Alogliptin with U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... -- regulated information — Global biopharmaceutical company UCB, Inc. and ... launch of a new Pledge campaign for people with ... empowers the millions of Americans living with ... commitment to demand more: greater understanding of the condition, ... partial-onset seizure control.  More information is available at ...
(Date:6/18/2013)... June 18, 2013 The "Bioinformatics Market By ... Knowledge Management Tools & Data Analysis Services) & Application (Genomics, ... the Major Market Drivers, Restraints, and Opportunities in ... Asia-Pacific and Rest of World. ... 22 Figures 364 ...
(Date:6/18/2013)... Canada (PRWEB) June 18, 2013 ... oversight of pharmaceutical advertising and promotion, and review ... Viewers will learn how to apply these principles ... examples:, ,     The fundamentals on FDA ... and promotional labeling ,     Assessing traditional and ...
(Date:6/18/2013)... June 18, 2013   Lexicon Pharmaceuticals, Inc. ... company focused on discovering breakthrough treatments for human ... has joined the company as its vice president ... brings extensive commercial experience to Lexicon, including both ... of therapeutic areas. Mr. Northcott has ...
Breaking Biology Technology:Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
... Expands Beckman Coulter,s Worldwide Position in Clinical ... in Chemistry and Automation Broaden Global Opportunity, ... Penetration of Beckman Coulter,s Immunoassay Products into ... Growth- Transaction Expected to be Accretive to ...
... MMR Information Systems, Inc. (OTC Bulletin ... subsidiary, MyMedicalRecords, Inc. (collectively, "MMR") provides consumer-controlled ... and electronic safe deposit box storage solutions ... investment banking firm Houlihan Smith & Co. ...
... Pa., Feb. 26 Globus Medical, Inc., the ... world, today announced the full launch of its ... a MILDER (TM) Anterior Lumbar Interbody Fusion ... interbody spacer into a preassembled, easy-to-use system that ...
Cached Biology Technology:Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 2Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 3Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 4Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 5Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation 6MMR Information Systems, Inc. Engages Houlihan Smith 2MMR Information Systems, Inc. Engages Houlihan Smith 3Globus Medical's INDEPENDENCE(TM) Spacer System: The MILDER(TM) ALIF Solution 2
(Date:6/17/2013)... their food may turn out to be just as important ... of St. Michael,s Hospital. , The study, led by ... association between poor eating habits in kids ages three to ... cholesterol, putting them at risk for cardiovascular disease later in ... Medical Association Journal today. , "We know that ...
(Date:6/17/2013)... ST. LOUIS -- In research published in Biochemical ... describe a technology that can detect new, previously unknown ... for viruses even when doctors have not identified a ... , In the new approach, scientists use ... discover viruses. , Taking advantage of the complete deciphering ...
(Date:6/17/2013)... As mobile devices, smartphones and tablets ... grows exponentially, and biometric authentication offers that security, ... Reading Insider ( www.heavyreading.com/mobile-networks ), a subscription ... www.heavyreading.com ). Biometrics Offer Promise for ... authentication on smartphones, analyzing the most lucrative verticals ...
Breaking Biology News(10 mins):Poor eating behaviors may put preschoolers at risk for later health problems 2Saint Louis University researchers discover a way to detect new viruses 2Saint Louis University researchers discover a way to detect new viruses 3Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3
... a chunk of its tail fin, it'll grow back within ... replace surprisingly complex body parts. A tail fin, for example, ... intricate structure. It is the fish version of an arm ... missing tails and other appendages has fascinated veterinary and medical ...
... at the University of Georgia, using glow-in-the-dark proteins ... function of a complex organelle in the bacterium ... described in new, precise detail the unique cell ... bacterium Mycoplasma pneumoniae. This structure, called a "terminal ...
... deep within the cells of fruit flies, developmental biologists ... in Philadelphia may have discovered a new way that ... they're right, and the same processes are at work ... have implications for improving the understanding of a range ...
Cached Biology News:How does a zebrafish grow a new tail? 2How does a zebrafish grow a new tail? 3UGA scientists unravel 'molecular inch-worm' structure of walking-pneumonia bacterium 2Jefferson researchers uncover new way nature turns genes on and off 2
... Fujifilm Life Science LAS-3000 imaging system ... a simplified user interface, providing significantly ... range of modularities. The system is ... the perfect standard system for Western ...
... Science LAS-3000mini is a compact image ... applications, and the perfect standard system ... LAS-3000 provides significantly improved system sensitivity ... calibration standards validate that Fujis LAS-3000 ...
... kit provides complete components including positive and ... DNA fragmentation in cultured cells and tissue ... of apoptotic cells. Internucleosomal DNA ... mammalian cells. MBLs ApoDIRECT In Situ DNA ...
SDS-OutT Precipitation Reagent...
Biology Products: